batanopride batanopride batanopride (bmy-25,801) is an antiemetic drug of the benzamide class which acts as a selective 5-ht3 receptor antagonist. it was trialled to reduce nausea during cancer chemotherapy, but was never approved for medical use due to dose-limiting side effects including hypotension and long qt syndrome. batanoprideclinical dataroutes ofadministrationoralatc codenonelegal statuslegal status in general: uncontrolled identifiers iupac name 4-amino-5-chloro-n-(2-diethylaminoethyl)-2-(3-oxobutan-2-yloxy)benzamide cas number102670-46-2 npubchem cid59692chemspider53849 yunii1at99k728nchemblchembl38594 ychemical and physical dataformulac17h26cln3o3molar mass355.86 g·mol−13d model (jsmol)interactive image smiles clc1cc(c(oc(c(=o)c)c)cc1n)c(=o)nccn(cc)cc inchi inchi=1s/c17h26cln3o3/c1-5-21(6-2)8-7-20-17(23)13-9-14(18)15(19)10-16(13)24-12(4)11(3)22/h9-10,12h,5-8,19h2,1-4h3,(h,20,23) ykey:zyojxunlloburp-uhfffaoysa-n y ny (what is this?) (verify)